Pharmaceuticals

Global Hypercholesterolemia Drugs Market 2016-2020

  • TEC629318
  • 98 Pages
  • July 2016
  • Pharmaceuticals
About Hypercholesterolemia

Hypercholesterolemia is characterized by high levels of total cholesterol and LDL-C in the blood. High cholesterol levels can cause CVDs such as stroke and atherosclerosis. The typical range of total blood cholesterol is 140-200 mg/dL.Blood cholesterol contains individual components such as LDL-C and HDL-C. LDL carries cholesterol to the body and HDL removes cholesterol from the cells by reversing cholesterol transport to the liver.

Technavios analysts forecast the global hypercholesterolemia drugs market to decline at a CAGR of 6.78% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global hypercholesterolemia drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generics, and off-label drugs used to treat hypercholesterolemia.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Hypercholesterolemia Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
AbbVie
Aegerion Pharmaceuticals
AstraZeneca
Merck
Pfizer
Sanofi

Other prominent vendors
Alnylam Pharmaceuticals
Amarin
Amgen
AtheroNova
Aurobindo Pharma
Biocon
Biospherics
Bristol-Myers Squibb
Catabasis Pharmaceuticals
Cerenis Therapeutics
Cipla
CJ HealthCare
CKD Bio
Concord Biotech
CymaBay Therapeutics
Daewoong Pharmaceutical
Daiichi Sankyo
Eli Lilly
Esperion Therapeutics
GlaxoSmithKline
HanAll BioPharma
JW Pharmaceuticals
Kadmon Pharmaceuticals
Kowa Company
Laboratoires
Livzon Pharmaceutical
Lupin Pharmaceuticals
Madrigal Pharmaceuticals
Merz Pharmaceuticals
Mylan
Novartis
Regeneron Pharmaceuticals
ReGenX Biosciences
Santaris Pharma
Serometrix
Sun Pharmaceutical
Arbutus Biopharma
Teva Pharmaceuticals
Torrent Pharmaceuticals
Zydus Cadila

Market driver
Rising prevalence of chronic diseases
For a full, detailed list, view our report

Market challenge
Loss of patent exclusivity of branded therapies
For a full, detailed list, view our report

Market trend
Expected entry of cost-effective OTC versions
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.






Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Nephrology and Urology Devices Market (Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013 - 2020)

Nephrology and urology devices are medical devices that are used for the treatment of urinary system and kidney diseases such as chronic kidney diseases (CKD), urinary incontinence and ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Acute Lymphoblastic Leukemia Therapeutics Market (Therapeutics and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

The Global Leukemia market involves acute and chronic conditions, namely acute myeloid leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia and chronic lymphocytic leukemia. Acute lymphoblastic leukemia is a hematological malignancy, ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Empty Capsules Market - Opportunities and Forecasts, 2015 - 2020b

Empty capsules enable users to fill bulking agents, fillers, colorants on their own in a capsule. It provides users scope to blend various ingredients and decide specifications of capsules. It ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Antipsychotic Drugs Market (Brand, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Antipsychotic drugs are also termed as major tranquilizers or neuroleptics and these are primarily used to treat psychosis. The common psychotic disorders, where these drugs are majorly used include schizophrenia, hallucinations, delusions, bipolar disorder and others.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Hemophilia Treatment Market (Type, Medicine and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Hemophilia is a hereditary genetic disorder which impairs body ability to control coagulation or blood clotting. In this disease, clotting factors control bleeding from a broken vessel is deficient; therefore, ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>